Sotalol: A rescue drug in the face of life-threatening refractory ventricular tachycardia.
Ann Card Anaesth
;
2014 Apr; 17(2): 170-172
Artículo
en Inglés
| IMSEAR
| ID: sea-150323
ABSTRACT
We describe postoperative refractory ventricular tachycardia (VT) in a patient following aortic and mitral valve replacement. Following an uneventful separation from cardiopulmonary bypass with dobutamine, the patient developed recurrent VT, 4 hours into the postoperative period. The VT did not respond to standard doses of xylocard, magnesium and amiodarone. Electrolyte and acid base parameters were normal. Multiple cardioversions failed to revert back to a stable rhythm. Intra‑aortic balloon pumping was instituted and overdrive right ventricular pacing was unsuccessful. Following intravenous sotalol 80 mg, the VT came under control and reverted to a nodal rhythm, which required atrial pacing for the next 8 hours. Oral sotalol therapy was continued at 40 mg daily. The VT did not recur.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Sotalol
/
Cardioversión Eléctrica
/
Humanos
/
Masculino
/
Taquicardia Ventricular
/
Adulto
/
Implantación de Prótesis de Válvulas Cardíacas
/
Atrios Cardíacos
/
Válvulas Cardíacas
/
Amiodarona
Idioma:
Inglés
Revista:
Ann Card Anaesth
Año:
2014
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS